Upgrade to SI Premium - Free Trial

Kimberly-Clark (KMB) Tops Q4 EPS by 2c, Slight Miss on Revenues; To Cut Workforce by 5,000-5,500

January 23, 2018 7:33 AM

Kimberly-Clark (NYSE: KMB) reported Q4 EPS of $1.57, $0.02 better than the analyst estimate of $1.55. Revenue for the quarter came in at $4.58 billion versus the consensus estimate of $4.59 billion.

2018 Outlook and Key Planning Assumptions

The company's key planning and guidance assumptions for 2018 are as follows:

GUIDANCE:

Kimberly-Clark sees FY2018 EPS of $6.90-$7.20, versus the consensus of $6.60.

Executive Summary

2018 Global Restructuring Program - Overview

The 2018 Global Restructuring Program is expected to reduce Kimberly-Clark's structural cost base and enhance the company's flexibility to invest in its brands, growth initiatives and capabilities critical to delivering future growth. The program will make Kimberly-Clark's overhead organization structure and manufacturing supply chain less complex and more efficient. Over time, the program is expected to accelerate the company's return to delivering sales and earnings growth in line with its Global Business Plan objectives and further enhance long-term shareholder value.

The company expects the program will generate annual pre-tax cost savings of $500 to $550 million by the end of 2021. Savings will be driven by workforce reductions, which are anticipated to be in a range of 5,000 to 5,500 (12 to 13 percent of current headcount), along with manufacturing supply chain efficiencies. The program is expected to broadly impact all of the company's business segments and organizations in each major geography. The savings are incremental to the company's ongoing FORCE cost savings program.

The company expects to close or sell approximately 10 manufacturing facilities and expand production capacity at several others to improve overall scale and cost. As part of the program, Kimberly-Clark expects to exit or divest some low-margin businesses that generate approximately 1 percent of company net sales. The sales are concentrated in the consumer tissue business segment.

To implement the restructuring program, the company expects total cash spending of $1,500 to $1,700 million by the end of 2020, consisting of $900 to $1,000 million in pre-tax cash restructuring charges and approximately $600 to $700 million in incremental capital spending.

The company also expects to incur non-cash restructuring charges of $800 to $900 million pre-tax by the end of 2020, making the total expected restructuring charges $1,700 to $1,900 million pre-tax ($1,350 to $1,500 million after-tax). Restructuring charges in 2018 are anticipated to be $1,200 to $1,350 million pre-tax ($950 to $1,050 million after tax). The company will exclude the restructuring charges when it reports adjusted results in future periods.

For earnings history and earnings-related data on Kimberly-Clark (KMB) click here.

Categories

Corporate News Earnings Guidance Hot Guidance

Next Articles